HL7 Europe Laboratory Report
2.1.0 - trial-use 150

This page is part of the HL7 Europe Laboratory Report (v2.1.0: STU 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Resource Profile: ObservationResultsLaboratoryEu - Examples

Page standards status: Trial-use Maturity Level: 2

Examples for the Observation-resultslab-eu-lab Profile.

Observation: certified reference material
Observation: urinalysis with differently reported components
Observation: urinalysis with a component without a result
Observation: urinalysis with a component reported as an attachment
Observation: urinalysis panel reported as an attachment
Observation: ratio example
Observation: Aerobic Culture example
Observation: Anaerobic Culture example
Observation: corrected glucose result
Observation: ABO group of a blood unit
Observation: potassium concentration of an infusion solution
Observation: Gram Staining example
Observation: Gram-positive cocci, observed quantity, example
Observation: Gram-positive cocci example
Observation: Staphylococcus aureus Growth example
Observation: Staphylococcus aureus Cephalothin susceptibility example
Observation: Staphylococcus aureus levoFLOXacin susceptibility example
Observation: Staphylococcus aureus Oxacillin susceptibility example
Observation: Staphylococcus aureus Vancomycin susceptibility example
Observation: Staphylococcus aureus susceptibility panel example
Observation: Staphylococcus aureus identified example
Observation: cancelled result with a status reason
Observation: Leukocytes Presence example